NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Good question. The way you phrased it, do you suspect that Northwest Bio is making false statements in their SEC filings? I doubt it, and I also doubt that a major ramp up is in progress, but I do think that Advent will soon be ready to add to the manufacturing capacity, which should be sufficient for the initial commercialization. I agree that even the Big Pharma companies will often seek initial approval in one market before expanding, so seeking approval in 4 countries simultaneously seems aggressive. But in this case, if one market decides to delay approval for some reason, then there are still multiple other opportunities in the other markets. I have thought that the UK/EU with their Hospital Exemption and PIM designation for DCVAX, seem more eager to approve it than the U.S., and maybe I’m not alone. Or maybe another reason is to create a broader available market to increase the buyout price?